Articles by Jef Feeley and Riley Griffin

J&J Hit with Year’s Largest Jury Award Over Marketing Risperdal Drug to Teens

Johnson & Johnson’s Janssen unit was hit with an $8 billion punitive-damages verdict — the largest jury award in the U.S. this year — over its alleged mishandling of an anti-psychotic drug blamed for causing adolescent boys to grow female-sized …

Opioid Trial Judge, Overseeing 2,000 Lawsuits, Denies Bias, Refuses to Step Down

The Cleveland judge overseeing more than 2,000 federal lawsuits over alleged opioid abuses refused to disqualify himself from a bellwether trial set to start next month, rejecting a request by drug distributors and pharmacies who say he is biased against …

Other Opioid Lawsuit Plaintiffs Welcome Oklahoma Ruling Affirming Public Nuisance

While some Johnson & Johnson investors were relieved that the company’s $572 million penalty for fueling Oklahoma’s opioid epidemic wasn’t as high as feared, lawyers for other U.S. states, cities and counties could hardly contain their glee. That’s because the …

Drug Maker Endo Skirts Trial, Settles Its Opioid Claims for $11 Million

Endo International Plc agreed to an $11 million settlement to avoid going to trial in the first federal court cases targeting opioid makers and distributors over the public-health crisis caused by the painkillers. Endo said Tuesday it will pay $10 …

J&J Vows to Overcome Baby Powder, Opioid Liability Claims Against It

Johnson & Johnson said that the health-care conglomerate will come out on the winning side of thousands of legal claims over its baby powder and opioid products. Last week, Bloomberg reported that the U.S. Justice Department was pursuing a criminal …

Opioid Maker Insys Files for Bankruptcy in Wake of Bribery Convictions, Probe Settlement

Drugmaker Insys Therapeutics Inc., whose former executives were convicted of bribing doctors to prescribe its highly addictive opioid, filed for bankruptcy protection after agreeing to pay hundreds of millions of dollars to settle a probe by U.S. prosecutors. The Chapter …

Insys Agrees to $225 Million Settlement of U.S. Claims of Illegal Opioid Sales

Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay $225 million to settle U.S. claims that the drug maker illegally sold opioid-based painkillers. Under terms of the deal, Insys …

Jury Finds Insys Founder, Execs Guilty of Racketeering in Opioid Sales

Insys Therapeutics Inc. founder John Kapoor was convicted of a racketeering conspiracy that drove sales of a highly addictive opioid while contributing to a nationwide epidemic. Federal jurors in Boston found that Kapoor conspired with four other executives to bribe …